Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational modelling for personalized transcatheter aortic valve replacement planning: a systematic review of complications and decision support.

Frontiers in digital health·2026
Same author

Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Cardiogenic Shock: Clinical Management, Outcomes and Future Directions.

Journal of cardiovascular development and disease·2026
Same author

A randomized crossover clinical trial comparing 24-h blood pressure measurements from two different cuffless wrist ambulatory monitors with cuffed ambulatory monitoring for translation to clinical practice: Rationale and Design of Continuum BP study.

American heart journal plus : cardiology research and practice·2026
Same author

Angiography-derived fractional flow reserve- vs usual care-guided percutaneous coronary intervention: interim analysis of the PIONEER IV trial.

European heart journal·2026
Same author

Comparison of Atheroma Burden Changes Using Conventional vs. End-Diastolic Intravascular Ultrasound Segmentation　- Post Hoc Analysis of the PACMAN-AMI Study.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same journal

Industry updates in advanced therapy medicinal products and regenerative medicine - May 2026.

Regenerative medicine·2026
Same journal

Ethical, legal, and social issues associated with human fetal tissue research in Japan.

Regenerative medicine·2026
Same journal

The future of hematopoietic stem cell and stem cell gene therapy for metabolic diseases.

Regenerative medicine·2026
Same journal

Exploring gene therapy for developmental and epileptic encephalopathies (DEEs): possibilities or promises?

Regenerative medicine·2026
Same journal

Industry updates in advanced therapy medicinal products and regenerative medicine - April 2026.

Regenerative medicine·2026
Same journal

Optimizing strategies in tendon tissue engineering through effective scaffold design: overview of recent advancements.

Regenerative medicine·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cell therapy in cardiology.

Fizzah Aziz Choudry1, Anthony Mathur

  • 1London Chest Hospital, Bonner Road, London E2 9JX, UK.

Regenerative Medicine
|October 18, 2011
PubMed
Summary
This summary is machine-generated.

Cell therapy, particularly bone marrow mononuclear cells, shows promise for cardiovascular disease treatment. Ongoing research and clinical trials are evaluating its safety, efficacy, and long-term outcomes.

More Related Videos

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: May 28, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Translational Medicine

Background:

  • Cell therapy is a key strategy for addressing unmet needs in cardiovascular disease treatment.
  • Bone marrow mononuclear cells (BMMCs) are the most studied cell type, with growing clinical data supporting their safety and biological activity.
  • Phase II/III trials for acute and chronic ischemia have confirmed the efficacy of BMMCs.

Purpose of the Study:

  • To review the current status and future directions of cell therapy in cardiovascular disease.
  • To highlight the progress and challenges in translating cell-based therapies from bench to bedside.
  • To discuss the potential of advanced cell therapy products and their comparative efficacy and cost-effectiveness.

Main Methods:

  • Review of published Phase I, II, and III clinical trial data.
  • Analysis of ongoing and planned large-scale outcome studies.
  • Discussion of emerging cell therapy approaches, including selected cell populations, bioengineered cells, and resident stem cells.

Main Results:

  • BMMCs have demonstrated safety and biological activity in clinical trials for ischemic cardiovascular conditions.
  • Phase I trials of advanced cell therapy products show promising initial results.
  • A large pan-European outcome study is planned to assess the mortality benefits of BMMCs.

Conclusions:

  • Cell therapy, especially using BMMCs, holds significant therapeutic potential for cardiovascular repair.
  • Further research and rigorous evaluation are necessary for more complex cell therapy products to demonstrate superior outcomes and cost-effectiveness.
  • The collaboration between scientists and clinicians is crucial for advancing cell therapy in cardiovascular medicine over the next five years.